Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

In-Silico Identified New Natural Sortase A Inhibitors Disrupt S. aureus Biofilm Formation.

Tytuł:
In-Silico Identified New Natural Sortase A Inhibitors Disrupt S. aureus Biofilm Formation.
Autorzy:
Thappeta KRV; Singapore Institute of Food and Biotechnology Innovation (SIFBI), Agency for Science, Technology and Research (A*STAR), 31 Biopolis Way, #01-02 Nanos, Singapore 138669, Singapore.
Zhao LN; Bioinformatics Institute (BII), Agency for Science, Technology and Research (A*STAR), 30 Biopolis Street, #07-01 Matrix, Singapore 138671, Singapore.; Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), 61 Biopolis Drive, #3-09 Proteos, Singapore 138673, Singapore.
Nge CE; Singapore Institute of Food and Biotechnology Innovation (SIFBI), Agency for Science, Technology and Research (A*STAR), 31 Biopolis Way, #01-02 Nanos, Singapore 138669, Singapore.
Crasta S; Singapore Institute of Food and Biotechnology Innovation (SIFBI), Agency for Science, Technology and Research (A*STAR), 31 Biopolis Way, #01-02 Nanos, Singapore 138669, Singapore.
Leong CY; Singapore Institute of Food and Biotechnology Innovation (SIFBI), Agency for Science, Technology and Research (A*STAR), 31 Biopolis Way, #01-02 Nanos, Singapore 138669, Singapore.
Ng V; Singapore Institute of Food and Biotechnology Innovation (SIFBI), Agency for Science, Technology and Research (A*STAR), 31 Biopolis Way, #01-02 Nanos, Singapore 138669, Singapore.
Kanagasundaram Y; Singapore Institute of Food and Biotechnology Innovation (SIFBI), Agency for Science, Technology and Research (A*STAR), 31 Biopolis Way, #01-02 Nanos, Singapore 138669, Singapore.; Bioinformatics Institute (BII), Agency for Science, Technology and Research (A*STAR), 30 Biopolis Street, #07-01 Matrix, Singapore 138671, Singapore.
Fan H; Bioinformatics Institute (BII), Agency for Science, Technology and Research (A*STAR), 30 Biopolis Street, #07-01 Matrix, Singapore 138671, Singapore.
Ng SB; Singapore Institute of Food and Biotechnology Innovation (SIFBI), Agency for Science, Technology and Research (A*STAR), 31 Biopolis Way, #01-02 Nanos, Singapore 138669, Singapore.; Bioinformatics Institute (BII), Agency for Science, Technology and Research (A*STAR), 30 Biopolis Street, #07-01 Matrix, Singapore 138671, Singapore.
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2020 Nov 14; Vol. 21 (22). Date of Electronic Publication: 2020 Nov 14.
Typ publikacji:
Journal Article
Język:
English
Imprint Name(s):
Original Publication: Basel, Switzerland : MDPI, [2000-
MeSH Terms:
Aminoacyltransferases*/antagonists & inhibitors
Aminoacyltransferases*/chemistry
Aminoacyltransferases*/metabolism
Anti-Bacterial Agents*/chemistry
Anti-Bacterial Agents*/pharmacology
Bacterial Proteins*/antagonists & inhibitors
Bacterial Proteins*/chemistry
Bacterial Proteins*/metabolism
Cysteine Endopeptidases*/chemistry
Cysteine Endopeptidases*/metabolism
Enzyme Inhibitors*/chemistry
Enzyme Inhibitors*/pharmacology
Biofilms/*drug effects
Staphylococcus aureus/*physiology
A549 Cells ; Biofilms/growth & development ; Computer Simulation ; Hep G2 Cells ; Humans
References:
Cell Microbiol. 2012 Oct;14(10):1513-21. (PMID: 22747834)
J Appl Microbiol. 2003;94(3):413-20. (PMID: 12588550)
Prog Drug Res. 2008;65:211, 213-49. (PMID: 18084917)
Nat Rev Microbiol. 2014 Jan;12(1):49-62. (PMID: 24336184)
Bioorg Med Chem. 2009 Oct 15;17(20):7174-85. (PMID: 19781950)
J Vis Exp. 2011 Jan 30;(47):. (PMID: 21307833)
JAMA Pediatr. 2015 Dec;169(12):1105-11. (PMID: 26502073)
Molecules. 2017 Oct 27;22(11):. (PMID: 29077016)
Future Med Chem. 2020 Mar;12(5):357-359. (PMID: 32027174)
J Med Chem. 2016 May 12;59(9):4103-20. (PMID: 26913380)
Eur J Med Chem. 2019 Jan 1;161:154-178. (PMID: 30347328)
EMBO J. 2008 Oct 22;27(20):2656-68. (PMID: 18800056)
Proc Natl Acad Sci U S A. 2000 May 9;97(10):5510-5. (PMID: 10805806)
Diabetes. 2000 Dec;49(12):2079-86. (PMID: 11118010)
Biofouling. 2010;26(4):433-8. (PMID: 20234952)
Molecules. 2015 Dec 04;20(12):21658-71. (PMID: 26690095)
Int J Antimicrob Agents. 2010 Apr;35(4):322-32. (PMID: 20149602)
J Antimicrob Chemother. 2005 Aug;56(2):331-6. (PMID: 15980094)
J Biol Chem. 2009 Sep 4;284(36):24465-77. (PMID: 19592495)
Nat Biotechnol. 2018 Jul 6;36(7):570-573. (PMID: 29979661)
Mar Drugs. 2018 Jul 13;16(7):. (PMID: 30011882)
Chem Rev. 2016 Aug 24;116(16):9162-236. (PMID: 27437994)
Int J Infect Dis. 2010 Oct;14 Suppl 4:S7-11. (PMID: 20851011)
Int J Mol Sci. 2017 Oct 23;18(10):. (PMID: 29065551)
Pharmacol Rev. 2008 Mar;60(1):128-41. (PMID: 18321961)
Microbiology (Reading). 2003 Mar;149(Pt 3):643-654. (PMID: 12634333)
Eur Respir J. 2009 Dec;34(6):1470-6. (PMID: 19948913)
ACS Infect Dis. 2020 May 8;6(5):1228-1237. (PMID: 32138506)
J Chem Inf Model. 2010 Sep 27;50(9):1561-73. (PMID: 20735049)
Philos Trans R Soc Lond B Biol Sci. 2012 Apr 19;367(1592):1123-39. (PMID: 22411983)
Lab Invest. 2007 Jan;87(1):3-9. (PMID: 17146447)
J Biol Chem. 2004 Jul 23;279(30):31383-9. (PMID: 15117963)
Trends Microbiol. 2001 Mar;9(3):97-102. (PMID: 11239768)
Proteins. 2009 Dec;77(4):778-95. (PMID: 19603484)
Nat Rev Drug Discov. 2010 Feb;9(2):117-28. (PMID: 20081869)
Biopolymers. 2010;94(4):385-96. (PMID: 20593474)
FEBS J. 2015 Jun;282(11):2097-114. (PMID: 25845800)
Bioorg Med Chem. 2019 Mar 1;27(5):721-728. (PMID: 30711310)
Lancet Infect Dis. 2016 Jul;16(7):767-768. (PMID: 27208976)
J Biotechnol. 2017 Sep 10;257:233-239. (PMID: 28647529)
Appl Microbiol Biotechnol. 2014 Mar;98(5):2041-51. (PMID: 23817664)
J Clin Microbiol. 2010 Mar;48(3):894-9. (PMID: 20089758)
Microb Pathog. 2014 Dec;77:105-12. (PMID: 25457798)
J Med Chem. 2009 Sep 24;52(18):5712-20. (PMID: 19719084)
Mol Microbiol. 2011 Dec;82(5):1044-59. (PMID: 22026821)
Mini Rev Med Chem. 2007 Oct;7(10):991-1000. (PMID: 17979801)
Curr Top Microbiol Immunol. 2008;322:207-28. (PMID: 18453278)
Lancet Infect Dis. 2005 May;5(5):275-86. (PMID: 15854883)
NPJ Biofilms Microbiomes. 2018 Feb 27;4:4. (PMID: 29507749)
Clin Microbiol Rev. 2002 Apr;15(2):167-93. (PMID: 11932229)
J Infect Dis. 2002 May 15;185(10):1417-24. (PMID: 11992276)
ChemMedChem. 2020 Oct 14;:. (PMID: 33090669)
Antimicrob Agents Chemother. 2016 Sep 23;60(10):5663-72. (PMID: 27401577)
Appl Microbiol Biotechnol. 2006 Mar;70(1):102-6. (PMID: 16010573)
Grant Information:
H16/99/b0/004 Biomedical Research Council (BMRC) Transition Fund of A*STAR, Singapore.
Contributed Indexing:
Keywords: MRSA; Staphylococcus aureus; anti-biofilm activity; fibrinogen; molecular docking; natural products; skyrin; sortase A inhibitor; virtual screening
Substance Nomenclature:
0 (Anti-Bacterial Agents)
0 (Bacterial Proteins)
0 (Enzyme Inhibitors)
EC 2.3.2.- (Aminoacyltransferases)
EC 2.3.2.- (sortase A)
EC 3.4.22.- (Cysteine Endopeptidases)
Entry Date(s):
Date Created: 20201118 Date Completed: 20210304 Latest Revision: 20210304
Update Code:
20240105
PubMed Central ID:
PMC7696255
DOI:
10.3390/ijms21228601
PMID:
33202690
Czasopismo naukowe
Sortase A (SrtA) is a membrane-associated enzyme that anchors surface-exposed proteins to the cell wall envelope of Gram-positive bacteria such as Staphylococcus aureus . As SrtA is essential for Gram-positive bacterial pathogenesis but dispensable for microbial growth or viability, SrtA is considered a favorable target for the enhancement of novel anti-infective drugs that aim to interfere with key bacterial virulence mechanisms, such as biofilm formation, without developing drug resistance. Here, we used virtual screening to search an in-house natural compound library and identified two natural compounds, N1287 (Skyrin) and N2576 ((4,5-dichloro-1H-pyrrol-2-yl)-[2,4-dihydroxy-3-(4-methyl-pentyl)-phenyl]-methanone) that inhibited the enzymatic activity of SrtA. These compounds also significantly reduced the growth of S. aureus but possessed moderate mammalian toxicity. Furthermore, S. aureus strains treated with these compounds exhibited reduction in adherence to host fibrinogen, as well as biofilm formation. Hence, these compounds may represent an anti-infective therapy without the side effects of antibiotics.
Zaloguj się, aby uzyskać dostęp do pełnego tekstu.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies